ORLANDO — AI can transform how dermatologists diagnose skin conditions including melanoma; however, without attention to equitability, specifically in skin of color, it could exacerbate disparities in care, according to a speaker here.
Health Professionals
Adewole Adamson, MD, MPP: Addressing Melanoma Diagnosis and Overdiagnosis
Adewole (Ade) Adamson, MD, MPP, FAAD, assistant professor in the Department of Dermatology at Dell Medical School, University of Texas at Austin, presented a session titled, “Approach to Melanoma Diagnosis" at the 2025 American Academy of Dermatology (AAD) Annual Meeting.
Dr Akkooi on Pathologic Review Discrepancies and Overtreatment Risks in Metastatic Melanoma
Alexander C.J. Van Akkooi, MD, PhD, FRACS, chair, Melanoma Surgery, Melanoma Institute Australia; associate professor, University of Sydney, discusses findings from the prospective EORTC-1208-MG registry study (NCT01942603), which, in addition to evaluating the outcomes of patients with minimal sentinel node tumor burden who were managed without complete lymph node dissection, evaluated the accuracy of local pathological review in diagnosing metastatic melanoma.
Genetically modified virus therapy reduces tumor size and enhances surgical success in skin cancer study
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A research team from MedUni Vienna and University Hospital Vienna has now investigated the effectiveness of a new type of therapy and achieved promising results.